11/14
07:09 am
antx
AN2 Therapeutics to Participate at Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
AN2 Therapeutics to Participate at Upcoming Investor Conferences [Yahoo! Finance]
11/14
07:00 am
antx
AN2 Therapeutics to Participate at Upcoming Investor Conferences
Medium
Report
AN2 Therapeutics to Participate at Upcoming Investor Conferences
11/13
04:00 pm
antx
AN2 Therapeutics Reports Third Quarter 2024 Financial Results, Provides Important EBO-301 Update and Highlights Progress Across Boron Chemistry Pipeline
Low
Report
AN2 Therapeutics Reports Third Quarter 2024 Financial Results, Provides Important EBO-301 Update and Highlights Progress Across Boron Chemistry Pipeline
10/17
07:00 am
antx
AN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (caused by Mycobacterium tuberculosis) and Malaria
Medium
Report
AN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (caused by Mycobacterium tuberculosis) and Malaria
9/11
05:34 pm
antx
Nontuberculous Mycobacterial Infection Market to Exhibit Growth at a CAGR of 13.4% in the US by 2034 | DelveInsight [Yahoo! Finance]
Neutral
Report
Nontuberculous Mycobacterial Infection Market to Exhibit Growth at a CAGR of 13.4% in the US by 2034 | DelveInsight [Yahoo! Finance]
8/28
04:00 pm
antx
AN2 Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Neutral
Report
AN2 Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference